wk’ Reductian Act of 15395, :16 EISGIYS are
`
`F’TC3fA!A-'13 {(33-13)
`Approved for use flwmsgh G'!!3‘!!?O'!c!», QMB E385?-é‘.-G32
`US. Fafiem and Traderrzaiés Oke, E_i,S. BEPARTMENT OF DiZiMMERiZIE
`siéied ta zesptmd is miietiim of infnmnikra §.Efi§E.‘S.‘S it 113
`I‘
`_ .3 vaiid OMB ctzmmi nuntbrez
`
`P
`
`TRANSMETTAL
`(ONf_‘.|“' FUR FEE?!‘ N{3N:‘:‘}‘?E3W3?i3N.4f_ .4PpUC.4TK)N-9 UNDER
`37 *3‘? ‘-55(8))
`
`E
`
`.F'%§?7€§-F?)-‘E-“_§r" E-*OCkE§(‘ N1’).
`Fiajiv R. Singh
`Piss? fsianisd ;‘m¢e.",-:‘os'
`COMPQS§T§‘3N:S C0N3Te5\.3NING FLUC3R5NE
`SUB-STITUTEB OLEFINS AND METHODS AND
`SYSTEMS USENG SAME
`Express Naif Lsfimf N0.
`
`APPLICATEDN ELEMENTS
`See MPEP »:‘§ia):\fEr' 688 ca3rw_‘.v':W:§I?g ufix’:'typ.§£en£ app.?k>3§§:.7.-‘I v:‘£3m‘2‘_=m’5.
`
`1
`
`'
`
`2
`
`Fee Transmittal‘ Form
`{F'T0z'SS’% T »:.~r equivaierst}
`See 3?’ CFR L2?
`Appficant asserts smut! entity status.
`
`3 El Applicant certifies mien: entity status. See 3? CFR 129,
`'
`Angsimni must atia-2‘: farm PTO.’.’3B4'§5A N 8 or ezzuivaieni.
`4.
`Spaecifil-cation
`33
`Umaf Pages
`Both fhe claims and abstract mus? 339:: on a new sage.
`{SEE MPEP § m.9_L“11:'aM‘c::‘;.'r-‘s.‘12rz<a4iis.'r no me :\.“e{a:rE':>? atramgxzcnex
`
`}
`
`§T»3t3! Sheers
`H3}
`|:| Drawir1g(5}{35
`{Tow Pages
`ln:vamor's Oath or Deciaraflon
`5.
`ymciuafing sr.'.*.~&.‘.ih:£e smimms m-zdey 3.7 GFR 1?. 34 -and
`oafhorazfiz-daiatim under 3.? CFF‘ iflfi:-j_.l
`
`}
`}
`2
`&erL~'!'n«; as an
`
`5-
`
`El Newly exemted {czrigEn.:3§ in copy)
`A mpy (mm a prior appficafim ('3? CFR 'U33(r_i}}
`A_n;3l§ca1ion Data Sheet ’.Se-9 n-3&9 bsdow.
`:47 ~:2.FR 1 5'6 1¥*ros»s.w-ya or ecg:i'u:a§'—:ni_3
`GD-RUM or 05-52
`in duplicaie, large éatde. as Cnmgtzziee F'rogra::: (".1-‘cme.=:x£-‘)5!
`
`|:| Landscape Tabie on SD
`Nucieotide andfor Amino Acid Sequence Submission
`{if appiiraffsl items a — C, are seqamirvenfi
`
`:3 El Computer Readame Farm {CREE
`Ea.
`Specificsmn Sequence Listing an:
`
`Commissioner far Patents
`ADDRESS TO.’ R0. Box MSG
`Atexandrfia, VA 22313-1450
`ACCGMPANYENE APPLSCATRDN PART3
`
`10. El Asaignment Papers
`(cow:-r sheei 8: dcn:ument{s}}
`
`Name of Assigrxee
`
`‘H.
`
`37 cm 3.73m Statement
`|:| Paw“ of Attorney
`(when there 55 an aswgneej
`12 |:| English Translation Documem (;1t'a_n;:!+-:at.~iae«)
`H
`infunnatian Disciosure Statemem:
`-
`P-5_Q.‘"‘38303 or PTCLT449}
`Copies cf citzzticxns afiasned
`Preiiiiminary Amendment
`
`14.
`
`~55" El Return Receipt Postcard
`{'MF‘EF § 503} {S-!:ou2‘d he s;:e<..\‘:I‘c.i.*sf';‘-' it-_nn':§:ed,E
`
`15
`
`-W
`
`'
`
`13.
`
`Certified‘ Copy of Prisriw Documantfis}
`{Jf fweigrz ,r.«ric':r.Fe‘y 5.3 ciaime-(.5)
`Nunpuhiication Request
`Under 35 U C Q: {"q){2_}(B}{s_} Appzecane rnusi mm foam »'»*T0:ss:35 or
`eqimaient.
`
`Other.
`
`TRACK 3 REQUEST FORM
`
`is. El Paper
`3. El CDAROM or €3D—R {2 comes); or
`C D Staiemems verify-iixg identirycrf above cogées
`{S} Benefit dams under 3?‘ CFR 1 3'8 and foreign g:-rieriiy ciaims under 155 must be induded in an Agpiicatson Data Sheei(AE1S].
`"Nests:
`{2} Far a;3p§:\‘.ations med under 35 USS. M ‘L the appkicatim must cmtain an ADS sgerjfiging fire amfiicant ifihe applicant is an
`asségnee; person ‘knvhozn the invemor is under an
`he assign, as persm vmn when-visie shows suffeciem gmprieraay
`in£en‘::=.i in the matter.
`3? CFR 't .4E's{i3}_
`13. CORRESPONDENCE ADDRESS
`
`The address 3.’:a‘.‘:{‘.»£‘.iE1{€{‘3 with Customer Number’.
`
`91‘ 9?0
`
`UR El Cmfimmfim 3635935 3939“
`
`
`
`——:
`—‘—
`sxenneth Ma 53,332.:
`March 25, 291:4
`,
`‘
`Kenneth Ma
`53,339
`
`Registration No.
`§M_3mey,Age,,t)
`
`Name
`
`;-\(}TIVE .3t".3l29«.‘§91=1 03.-"'-.,.~
`
`Arkema Exhibit 1045
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`.
`.
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`
`D Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`Inventor
`Legal Name
`
`1
`
`‘
`
`Prefix Given Name
`Middle Name
`Family Name
`_2
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`StateIProvince
`NY
`country of Residencei I US
`
`Mailing Address of Inventor:
`
`Address ‘I
`
`Address 2
`
`18 Foxfire Drive
`
`City
`
`Getzville
`
`Stater'Province
`
`NY
`
`Inventor
`
`2
`
`Legal Name
`
`Midd'°Name
`
`Fami'v"am-°-
`
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`
`StatelPr0VinCe
`
`Country of Residence I
`
`Mailing Address of Inventor:
`
`136 Larkspur Lane
`
`Amherst
`
`I 14228
`
`I StateIProvince
`I Country i
`I US
`
`I NY
`
`Address 1
`Address2
`
`City
`Postal Code
`Inventor
`3
`Legal Name
`
`Given Name
`Ian
`
`Middle Name
`
`Family Name
`Shankland
`
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`_
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`H0O03965DIV1E
`
`.
`.
`Title of Invention
`
`City
`
`Buffalo
`
`StateIProvince lNY lcountry offiesidencel
`
`US
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`6 Horizon Court
`
`Buffalo
`
`| StateIProvince
`City
`l Country i
`l US
`l 07869
`Postal Code
`Inventor Information blocks may be
`All
`Inventors Must Be Listed — Additional
`generated within this form by selecting the Add button.
`
`| NY
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`D An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`
`Email Address
`
`Add Email
`
`Application Information:
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND
`SYSTEMS USING SAME
`
`Title of the Invention
`
`Attorney Docket Number HOOO3965DIV1E
`
`Small Entity Status Claimed
`
`|:|
`
`Application Type
`
`Nonprovisional
`
`Subject Matter
`
`Utility
`
`Total Number of Drawing Sheets (if any)
`
`Suggested Figure for Publication (if any)
`
`Filing By Reference:
`
`Only complete this section when filing an application by reference under 35 U.S.C. 111(c) and 37 CFR1.57(a). Do not complete this section if
`application papers including a specification and any drawings are being filed. Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e., ”Domestic Benefit/National Stage |nformation" and "Foreign Priority Information”).
`
`For the purposes of a filing date under 37 CFR1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previously filed application, subject to conditions and requirements of 37 CFR1.57(a).
`
`Application number of the previously
`filed application
`
`Filing date (YYYY-MM-DD)
`
`Intellectual Property Authority or Country i
`
`Publication Information:
`
`Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`Request N01: ‘I20 Publish. I hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 0113172014. OMB 0651-0032
`U.S. Patent and Trademark Otfice; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`H0O03965DIV1E
`
`.
`.
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`Customer Number
`
`@ Customer Number
`
`0 US Patent Practitioner O Limited Recognition (37 CFR 11.9)
`
`Domestic BenefitlNationa| Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C.119(e),120,121, or 365(c) or indicate National Stage
`entry from a PCT application. Providing this information in the application data sheet constitutes the specific reference required
`by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`When referring to the current application, please leave the application number blank.
`
`Prior Application Status
`
`Pending
`
`Application Number
`
`Continuity Type
`Division of
`
`Prior Application Number
`13844206
`
`Filing Date (YYYY-MM-DD)
`2013-03-15
`
`Prior Application Status
`
`Pending
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Status
`Application
`Number
`11847192
`
`Patented
`.
`.
`Continuity Type
`
`Prior Application Status
`
`Expired
`
`Prior Application
`Number
`10837525
`
`Filing Date
`(YYYY_MM_DD)
`2004-04-29
`
`Patent Number
`7279451
`
`|5SUe Date
`(YYYY_MM_DD)
`2007-10-09
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`10694273
`
`Claims benefit of provisional
`
`60421263
`
`2002-10-25
`
`Prior Application Status
`Application Number
`
`Expired
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`10694273
`
`Claims benefit of provisional
`
`60421435
`
`2002-10-25
`
`Prior Application Status
`Application
`
`Patented
`.
`
`.
`
`Prior Application
`
`Filing Date
`
`|SSUe Date
`
`11847192
`
`Continuation in part of
`
`10694272
`
`2003-10-27
`
`7230146
`
`2007-06-12
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`EFS Web 2.2.11
`
`d
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Attorney Docket Number
`_
`_
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`H0O03965DIV1E
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`
`constitutes the claim for priority as required by 35 U_S_C_ 119(b) and 37 CFR 1_55(d)_ When priority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (PDX) ‘the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1_55(h)(1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g)(1).
`
`Application Number
`
`Country I
`
`Filing Date (YYYY—MM—DD)
`
`Access Codei (if applicable)
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`D 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`16, 2013, will be examined under the first inventor to file provisions of the AIA.
`
`Authorization to Permit Access:
`
`Authorization to Permit Access to the Instant Application by the Participating Offices
`
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 0113172014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`H0O03965DIV1E
`
`.
`.
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked ifthe applicant
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy ofthe instant patent application with respect
`to: 1) the instant patent application-as-filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)—(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any U.S. application-as-filed from which benefit is
`sought in the instant patent application.
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date of filing this Authorization.
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`1
`Applicant
`Ifthe applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`0 Legal Representative under 35 U.S.C. 117
`
`0 Joint Inventor
`
`0 Person to whom the inventor is obligated to assign.
`
`0 Person who shows sufficient proprietary interest
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Name of the Deceased or Legally incapacitated Inventor :
`
`If the Applicant is an Organization check here.
`
`Orgamzatmn Name
`
`Honeywell International Inc.
`
`Mailing Address Information:
`Address 1
`101 Columbia Road
`
`Address 2
`
`City
`
`Country i US
`Phone Number
`
`EFS Web 2.2.11
`
`Morristown
`
`StateIProvince
`
`NJ
`
`Postal Code
`Fax Number
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`H0O03965DIV1E
`
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`Emai'/“dress
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Add
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`have an assignment recorded by the Office.
`
`Assignee
`
`1
`
`Complete this section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`application publication . An assignee-applicant identified in the "Applicant |nformation" section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assignee is also desired on the
`patent application publication.
`
`If the Assignee or Non-Applicant Assignee is an Organization check here.
`
`Given Name
`
`Middle Name
`
`Family Name
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`Address 1
`
`Address 2
`
`City
`
`Country i
`
`Phone Number
`
`Email Address
`
`StateI'Province
`
`Postal Code
`
`Fax Number
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`selecting the Add button.
`
`Signature:
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`Date (YYYY-MM-DD)
`lKenneth Ma63,839/
`T Resection Number
`
`2014-03-25
`63839
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number
`
`H0O03965DIV1E
`
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount oftime you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.11
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`(1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process andlor examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements ofthe Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or hislher designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuan
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.2.11
`
`

`
`IN THE [L-\‘ITED STATES PATENT AND I'RA{}EMARK OFFXCE.
`
`Quake: N0; HU(}U3965D1"V1E
`
`{PATEENTT}
`
`I11 re PatentA_10p1ica.ti0n of:
`Rajiv Rm Singh et 31.
`
`Appiicatian Na; N91” Y-at Assigned
`
`Confimlatimn No.1 N./'A
`
`Filed: C‘.cs31cu11'ent}3= Herewith
`
`A1‘tUm7t:
`
`Fm‘? CQMP{}SITH}N'S {?{)NTAfl\flN€} FL-UORINE.
`SUBSTITUTED OLEFBNFS AND METHODS
`AND S“fSTEMS SING SAME
`
`Examiner: Net Yet Assigned
`
`FIRST PREvLI=.\~'I}1‘3AR‘&" .-*-LNiE.ND:‘aIENT UNDER 37 C.F.R. 1.115
`
`{3u1m11issi0n:"::' fur Patenix
`
`P0. Bax 1450
`
`Aiexandiia, VA '2 23 13 - 145$}
`
`Dear Madam:
`
`INTRODUCTORY CTOMMENTS
`
`Prior I0 exfllllillfififlll an the merits, please anle-.m‘i the abm-*e.—1'deniifie.d US. pan-:~n‘I appiiszatima as
`
`foiiows:
`
`Amendments to the Specification begin e+11page 2 of 331$ pa~.pe1i.
`
`Amendments tn the Claims are raflected in ihe iisfing Muf ciailmzz which begins on page §4 cf fins
`
`paper.
`
`Remarks.é'A1'gu11:ents begin on page 15» of this p-apex‘.
`
`ACTIVE. 35213490171 E$3<"‘36e"2U } 4 16:47 AISJC fl"
`
`’
`
`

`
`;—Xpp§icatiG11N-ts. Not Ya Assigaked
`Preliminary A:;1.e1"zsimem
`
`5
`
`Docket
`
`: HGOi)3I9{35{)IX-“'213E
`
`TD THE SPE{IIFICA'}_"IG'N
`
`Please 1’ep1a.Ce' the current spec.i'fica.ti-:311 mm the S‘ubstiim'e Speazificaiion. Maxked up ccvpies
`
`Of the Stzbstiilite Specificaiiozl, as Wei} as a. 2162111 cap}: 0f the S\1bSEi{11‘(€‘ Specification, are stuhxxlifleii
`
`co'ncu1‘1'ent1§f }1e1‘ewi1‘h. No new 1113.131‘ is acfdszd.
`
`ACTIVE 3SZ.I3:1i->0‘.-'1 §33«"‘3x’)e"Zt'H4 19247 A13.-iC;."I
`
`,'_
`
`

`
`;—Xpp§icatiG11N-is. Not Yei Assigaied
`Preliminary z3\.1"i}.t‘:fi£i1'i1€Iii’
`
`:
`
`Docket
`
`: HGOi)3I9é5{)IX-“'213E
`
`ARHINDMENTS TO THE CLAI3\\'i.S
`
`Ii. — Bi}. {Canceled}
`
`2}“ {New}
`
`A 1'1)?-'ii}Dij far pmd'm:»ing an auiniimbiie aji‘ £tc:mii§.imijn sysiseiii fin‘ use wiih
`
`2,
`
`3, 3-’{ef1‘aflm1'op1'0pe11e{EH30-123433) c0mp1‘i:=,ing:i
`
`{a} pim-*id'u1g an i'i,1lTUi‘110biie va.po1" s:.0inp1'ession air ctmiditimiing 5}-‘stein usabie with
`
`1‘ef1‘ige1'a11i L1,1,2.—tetrafl1101'Qetha11e {HFC-1343} and hat-‘ing at least one mnipressor and at
`
`least 011:’: condenser; and
`
`{I3} p1'0widi11g a heat t1'a1isfe1' cmi'1}.m.<_:i‘iicsn in said systein, saidi1eatf1‘a11sfei" composition
`
`censistii1g essentiafij,-' of:
`
`(i) at least about 5G‘?=rb by weight of a 1‘efrige1'311tcm1sisiing essentially sf EFL)-
`
`i234;»'f ; and
`
`{ii} hibricaiit coiisisting esseiitiaily of poi;-*a}}.jrlei1e gi§_Js:0i;(‘s»), and
`
`whe31‘e.in {1} said c011de1ise:1' is cpemble with s.aid1‘efrigem11t in a temperature range that
`
`includes ISOQF and (E) saiii system wiien opemtiiig an El camdeusei‘ tempe1‘a.m1‘e of 153°?
`
`achieves a ca.pac.i’r§,-' i‘eiative ta HE(?—’i34a. (Pf about 1 and a Cmefficient of Pe1‘fom1a11ce (COP)
`
`relative in HFC-13422 of about 1.
`
`22.. {New}
`
`The iiiethed of claim 21 wiierein said i11b1‘ic.3.nt is presezit in the iiem. €I'&I1Sf€1'
`
`composition in an aiimunt of f1‘OD1 about 3(}% ts) about 5{}% by weiglit.
`
`23.. (New)
`
`The inetiiod of ciaim 21 wherein said HFQ-1234}-"f is presem i11theheat
`
`tmiisfez‘ czc-nipcsitiou in an EIIIIUUIIT, of at is-East about ?D% by weight.
`
`2~—’£.i {New}
`
`The iilethod of c-Eaim 21 wheiwziii said 1<ef1'ige1'ani1Las nu siibstalitial acute
`
`to:«:i<:it3-= as mea.<_:111'ed by inilalatimi eiapcssure in mice and rats.
`
`

`
`;—Xpp§icatiG11N-ts. Not Ya Assigaked
`Preliminary A:;1.e1"zsimem
`
`"
`
`Docket
`
`: HGOi)3I9{35{)IX-“'213E
`
`(New)
`
`Th~2.§11eYhm‘1c:f :3-Emm 3-A-1 wlhenzin said 1'ef1'1'ge1‘m1t11as 3 GEnha3_Wa11niz1g
`
`Pmezutiai (GK-VP} of net gmafez‘ {$1311 .1-!b{)11i 158“
`
`225. {New}
`
`A 111:‘-.thod af £OIli3i¥.§0i1iBg file air in an automobiie ‘using an automobiia air
`
`coiiciitéoning 53-‘SE13: including at lea st one cm11p1'es.s01‘_._ a‘t}ea.:si011e condenses‘ and at Beast
`
`one evaporatol‘, said method C{)iIlp1‘iSiI1g2
`
`{3} utiiizing in said 53-=sf.e111 a.11eat ’[1’ausfe.1‘ L‘.()l11p(§Sifi()11 mnsi.sn?11g §:s;~_:e11tiai}y of:
`
`{i} at least abaut 50% by weight ofa 1‘efi‘igeI':iI3JI szmlsistingg esszemiafly {Rf
`
`3, 3: 3-
`
`te:t1'aflL101'op1'op:211e {}EF{)-123431); and
`
`(ii) h1‘m‘ic.ant c0nsis’r,i11g esseiltially 0f§J»0E}Fa§§yle11e gfi}-‘C-9l(:5)V; silk}
`
`{1}} removing heat fmm said HFO-i334yf by c.o1'zden.sing said1‘efiige1’a11t in said C—m_‘1d€I1SE€1‘
`
`when said cmdensei‘ is cspeititing m'e1'a te:11pve1'afm‘e range Ehat that inchldes ab»:mt' §5G"F.
`
`27. {New}
`
`The nlethad of ciaml 26 whereizi said 1'ef1'ige1‘a11tachieves in said s3=ste1n a
`
`Meaapacity 1‘e1ati\Ie to HFC—} 343 Bf about 1 and 3 {IUeffic.iem Qf Pe1‘f01‘mam:e {COP} 1‘e1e1tive to
`
`HFC—}34a of about 1.
`
`28. {New}
`
`The xnethod of Chaim 26 wherein said hlbxicam is p1'esent in the heat F1'&:1‘1.Sf€i’
`
`compcssiiiou in an anmzint of frorn abom 30% to about 50% by weight.
`
`29. {New}
`
`The methad of ckainl 27 wherein said HTC3—123«“1yf is presem in the heat
`
`tmnsfez‘ c0n1p0siti011in an amount of at least about ?i)% by weight.
`
`30% {New}
`
`The nlethod of c-Rain} 29 wherein said 1<ef1'ige1'ant1Las nu Sllbfitélllfial acute
`
`toxicit}-= as mea.<_:111'ed by inilalation eyapcssure to mice and rats.
`
`31. (New)
`
`The n1et1m»:i cf cL';u?111 T4) whereiix said 1'efrige1‘311thas a.GEObaiWan11ing
`
`Putenfriai {GWP)nVf110tg1‘eat:':1' than about ESOE
`
`

`
`;—Xpp§icatiG11N-ts. Not Yex Assigaked
`Preliminary Amexzsitxxem
`
`,_
`
`Docket
`
`: HGOi)3I9é5{)IX-“'213E
`
`33... (New)
`
`A 31ea.t t1'ansi}':1' eoinpesifion fer use in an a11t0mnbfie air CQ11dii§.~i111i11g system
`
`of the type having 21 cemdeuse:1'Cspe1'a.ii31g in :1 i'EH}§J~EZI3.{11I€ mhge that inehides about. 15«0““F.
`
`said hem ‘m.‘a.11sie1‘ r.:0.n1p0:siTm11 consistilig essemiaiiy of:
`
`{3} at ieast ehmlt 5393133’ weight of a 1"ef1ige1'a1§1‘ c:hm15is€ing essen‘ria}Ijy* of 2., 3, 3, 3-
`
`f.etmflum'op1‘ope11e {HFO-12343-1}; and
`
`{ii} h1b1'ica=nt coilsisimg BSS€‘I}iiaH}’ Csf polyakyleiie gl§-'ee§{s)V_.
`
`wherehixx said1'efi’1'ge1‘antunderthe eomiifions cf sairiecvm3‘e11se1‘0pe:'atin§g at abem
`h
`. .,
`.i5{3°F in said automobile air x:011diTiening syatexn has 21 Car1.pi'iiZii)’1'831EifiVE‘. $0 }{F{.-1 .3421. of
`
`about 1 and a Caefficienf ef P-e1‘f01“1'112mee: (COP} I‘<'3-L’~iti%’6 to EEC-1343 efabeau? 1,
`
`33. {New}
`
`The heat hmzsfvex :tca111pcssiii01‘1 0feiain1 mm-.m said 1'1ea.tt1‘aesfe1‘
`
`eompositioix has {me iiqilid phase 01761‘ the ten1perahu‘e rzmge of fiem ahcnit --38°C re abmjt
`
`+50“‘C.
`
`34. {New}
`
`The heat t1‘ssnsI'e1‘c-onlpesiiioll efeiailn 33 wherein said lubricant is p1‘esen{i31
`
`fhe heat.t1'm15ie1's:0I11p0siti011 in an amcsmlt of from abcsui 30% to abom 50% by weight.
`
`35. {New}
`
`The heat transfel‘ eosllpesiiien of claim 32 wherein said HFO—£234yfi5
`
`present in theheatt1‘ax1sie1' COI}1pOSi‘[iUfl in an ammmt of at least about “E0”?--"Ia by weight.
`
`36. (New)
`
`Theheat1'1'a113fer emnpesiti011 of c}ai111 35 w11ereh1 said ref:‘ige1‘a11tha.<; no
`
`stzhstantiai a.cuie ie3(ie»it._\»= as mea.sm'ed by inhalaiign eyzpasure to mice and rats.
`
`37. (New)
`
`The heat trm’1sf»ex‘c0111p0siiion ofeiaim 36 wherein said ref1‘igera11tha.s a
`
`GiobhalWarn1h1g Potential {€311-’P)h Uf not greater $31311 abom 150.
`
`38. (New)
`
`The heat t1‘zmsI'7ee1‘e0n1positi011 efeiainl 37 wherein said1"efi’ige1‘a11t eesnsists of
`
`HF‘O—1234fA'f.
`
`39. {New}
`
`A nlethmi f01'pr0vid1'11g 3 system for cooling air in an automobile s:0mp1‘ising:
`
`ACTIVE. 352132190X?! 93:‘
`
`‘(H4 1-133;?-7’ AI\si;-‘.'_ .'
`
`

`
`;—Xpp§icatiG11N-ts. Not Ya Assigaked
`Preliminary A:;1.e1"zsimem
`
`I
`
`Docket
`
`: HGOi)3I9é5{)IX-“'213E
`
`{:3} p1's:>‘<.ririi11gin the m3’t,om0'i3iie. 3 vapor s:0mp.ns:ssio13. air co11c§itim1§11g sjzstem having at least
`
`one c0mp1'ess01‘ am} at least. {me CO11dt‘T1S€1'I
`
`311:3
`
`{B} p1‘m~‘idin_g:_ in said S‘§=‘S|fiiI11 5: heat traxlsfez‘ co-mpesitiuxz cm1si5ii11g.es$e:m'.ia1i§‘ of:
`
`(i) a.tieastai}0L1t5£3% by weighfi ofa refiigerant consisfing esseniiaikjr of
`
`.1, 3, 3-
`
`-V
`
`tet1“afl1101'op1‘0pene (iHFO—'123ziyf); and
`
`{ii} h1b1'icant emlsistiilg ess:':11tia1Rj_»~' ofpo1§*al§jy'1e11s: g1§:c0i{’s)5 and
`
`wherein ( 1) said L"»U11ds3fl5€‘1‘
`
`is aperable with said 3’e.f1’i.gs2era‘m in a ten1pr3.1":7n‘ure range that
`
`illssludes 150‘? and (2) said SYSTEIE1 opemiiiag at 23 c01'1ds:I1se1' te1:1pe1’:mu'e of lS€4°’F achieves a
`
`caparcitj.-‘ 1<e1aIive ice HFC-1343 of 3130111 '1 zlnd a Coeffiszient of Pe1'f9nna11::e {CC)P}1’ei3ti\-‘:3 1.9
`
`HF(.‘f—}3'4a of ab::2L1t 1.
`
`:10. {New}
`
`The n1eth0d of ckaml 39 whe1'§:in (A) 3aid1'e-fiigeralxt has 110 slzbstantiai acme
`
`toxici‘i;.* as nleasured by inhalation xifXp0Sui‘€
`
`ta ;m"c:': and mtg; (B) has 2': {fiflrahal Warming
`
`Pete11n'a1{GWP)n~fnotg1‘eate1‘than abcsut 159; :u1d(TC?} said HFO-1;’23v—"¥yf is pl7ESi311¥ in the
`
`heatt1‘a:t1sfe1’c01npositien in an 1111101111: of at least atmm 7{}% by weight.
`
`ACTIVE 3